FDA recall D-0789-2017

Baxter Healthcare Corporation · Class II · drug

Product

Milrinone Lactate in 5% Dextrose Injection, 20 mg/100 mL, 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-6010-48

Reason for recall

Lack of assurance of sterility: customer complaints received for the presence of leaks.

Distribution

US and foreign countries: United Arab Emirates, Colombia, and Canada

Key facts

Status
Terminated
Initiation date
2017-05-15
Report date
2017-05-24
Termination date
2018-08-10
Voluntary/Mandated
Voluntary: Firm initiated
Location
Deerfield, IL, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0789-2017